| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/19/2007 | US20070167440 Novel pyrrolidine compound and a process for preparing the same |
| 07/19/2007 | US20070167439 N4-(1-tert-Butoxycarbonylazetidin-3-yl)-5-fluoro-N2-(4-morpholinophenyl)-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE ("Fc epsilon RI") and IgG ("Fc gamma RI") antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis |
| 07/19/2007 | US20070167430 Compounds useful in therapy |
| 07/19/2007 | US20070167410 cyclic oximes useful in treatment or prevention of diseases mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction; 3-{[5-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-5,6,7,8-tetrahydro-naphthalen-2-ylmethyl]-amino}-propionic acid |
| 07/19/2007 | CA2634558A1 Oxaphenanthrene derivatives |
| 07/19/2007 | CA2633701A1 Novel, acyclically substitued furopyrimidine derivatives and use thereof |
| 07/19/2007 | CA2633698A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 07/19/2007 | CA2626641A1 Compounds |
| 07/18/2007 | EP1807420A1 Trisubstituted thiophenes as progesterone receptor modulators |
| 07/18/2007 | EP1807415A2 Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 07/18/2007 | EP1725239B1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy |
| 07/18/2007 | EP1509537B1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
| 07/18/2007 | CN1326858C Novel tricyclic spiropiperidines or spiropyrrolidines |
| 07/18/2007 | CN101001862A Tricyclic compounds and their use as MGLUR1 antagonists |
| 07/18/2007 | CN101001850A Amido compounds and their use as pharmaceuticals |
| 07/17/2007 | US7244853 Dioxanes and uses thereof |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244727 Fused bicyclic nitrogen-containing heterocycles |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |
| 07/17/2007 | US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog |
| 07/17/2007 | CA2395558C Intermediates for 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 07/17/2007 | CA2132887C Tricyclic 1-aminoethylpyrrole-derivatives |
| 07/12/2007 | WO2007077469A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/12/2007 | WO2007077443A1 Process and intermediate for preparation of donepezil |
| 07/12/2007 | WO2007077186A1 Pdf inhibitors |
| 07/12/2007 | WO2007045686A3 Intermediate and process of preparation of ecteinascidin such as ecteinascidines-583, 597 using such intermediate |
| 07/12/2007 | WO2007038459A3 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
| 07/12/2007 | WO2007027780A3 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/12/2007 | WO2007024651A3 Bridged n-bicyclic sulfonamido inhibitors of gamma secretase |
| 07/12/2007 | WO2007023507A3 Oxazolidinones bearing antimicrobial activity composition and methods of preparation |
| 07/12/2007 | WO2006078809A3 Method for the preparation of maytansinoid esters |
| 07/12/2007 | US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/12/2007 | US20070161693 6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione's as proteasome inhibitors, used to treat conditions mediated directly by the proteolytic function of the proteasome such as muscle wasting |
| 07/12/2007 | US20070161668 Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications |
| 07/12/2007 | US20070161630 Tricyclic tetrahydroquinoline antibacterial agents |
| 07/12/2007 | US20070161627 Antibacterial agents |
| 07/12/2007 | US20070161621 Spiroazacyclic compounds as monoamine receptor modulators |
| 07/12/2007 | DE102006002427A1 Neue Lysolipin Derivate New Lysolipin derivatives |
| 07/12/2007 | CA2635550A1 Process and intermediate for preparation of donepezil |
| 07/12/2007 | CA2633804A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/11/2007 | EP1805154A2 Pharmaceutical compositions |
| 07/11/2007 | EP1805150A2 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1805144A1 Heterocyclical chromophore architectures |
| 07/11/2007 | EP1309597B1 Polymorphs of an epothilone analog |
| 07/11/2007 | EP1175398B1 Indoline derivatives as progesterone antagonists |
| 07/11/2007 | EP1140907B1 Triazole compounds with dopamine-d3-receptor affinity |
| 07/11/2007 | CN1997646A Diphenylimidazopyrimidine and -imidazole amines as inhibitors of beta-secretase |
| 07/11/2007 | CN1995039A Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/11/2007 | CN1325501C Heterocyclic compounds |
| 07/11/2007 | CN1325500C Furyl compounds |
| 07/11/2007 | CN1325499C Thienyl compounds |
| 07/11/2007 | CN1325476C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents |
| 07/11/2007 | CN1325473C Novel azasugar derivative and drug containing the same as the active ingredient |
| 07/10/2007 | US7241892 Hemisynthetic method and new compounds |
| 07/10/2007 | US7241886 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b, f/azepine-5-carboxamide and 10,11-dihydro-10-oxo-5h-dibenz/b, f/azepine-5-carboxamide |
| 07/10/2007 | US7241796 Peptidomimetic compounds |
| 07/10/2007 | US7241781 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 07/10/2007 | US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 07/10/2007 | US7241745 Pyridyl alkene and pyridyl alkine acid amides as cytostatics and immunosupressives |
| 07/10/2007 | CA2378628C New indenoindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/05/2007 | WO2007076127A2 Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators |
| 07/05/2007 | WO2007075825A2 Lipophilic anticancer drug compounds |
| 07/05/2007 | WO2007075528A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 07/05/2007 | WO2007075492A1 Lipophilic anticancer drug compounds |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007074940A1 P2x4 receptor antagonist |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007038138A3 Amido compounds and their use as pharmaceuticals |
| 07/05/2007 | WO2006069080A3 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | US20070155964 Naphthols useful for preparing indeno-fused photochromic naphthopyrans |
| 07/05/2007 | US20070155815 Salinosporamides and methods for use thereof |
| 07/05/2007 | US20070155788 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155778 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments |
| 07/05/2007 | US20070155777 Antiinflammation agents |
| 07/05/2007 | US20070155776 Thienopyridine and furopyridine kinase inhibitors |
| 07/05/2007 | US20070155775 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
| 07/05/2007 | US20070155739 Substituted bis-amide metalloprotease inhibitors |
| 07/05/2007 | US20070155738 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155737 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155732 Aryl or Heteroaryl Fused Imidazole Compounds as Anti-Inflammatory and Analgesic Agents |
| 07/05/2007 | US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 07/05/2007 | US20070155723 Tetrahydro-pyranopyrazole cannabinoid modulators |
| 07/05/2007 | US20070155720 Co-administration of dopamine-receptor binding compounds |
| 07/05/2007 | US20070155718 Caspase inhibitor prodrugs |
| 07/05/2007 | US20070155715 Rifamycin analogs and uses thereof |
| 07/05/2007 | US20070154890 Method for detecting biomolecule, labeling dye used therefore, and labeling kit |
| 07/05/2007 | DE102005061171A1 Neue, cyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New, cyclic, substituted Furopyrimidin derivatives and their use |
| 07/05/2007 | DE102005061170A1 Neue, acyclisch substituierte Furopyrimidin-Derivate und ihre Verwendung New acyclic Furopyrimidin substituted derivatives and their use |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2633653A1 Heterocyclic derivatives as modulators of ion channels |
| 07/04/2007 | EP1803725A1 Methods for preparing irinotecan |
| 07/04/2007 | EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring |
| 07/04/2007 | EP1802630A2 Trityl derivatives for enhancing mass spectrometry |
| 07/04/2007 | EP1802629A1 Difluoro-substituted imidazopyridines |
| 07/04/2007 | EP1802609A2 Thrombin receptor antagonists |
| 07/04/2007 | EP1802602A1 Substituted dipiperdine ccr2 antagonists |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |